These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31664765)

  • 1. Relationship Between Plasma Concentrations and Clinical Effects of Cariprazine in Patients With Schizophrenia or Bipolar Mania.
    Periclou A; Willavize S; Jaworowicz D; Passarell J; Carrothers T; Ghahramani P; Durgam S; Earley W; Kapás M; Khariton T
    Clin Transl Sci; 2020 Mar; 13(2):362-371. PubMed ID: 31664765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial.
    Durgam S; Starace A; Li D; Migliore R; Ruth A; Németh G; Laszlovszky I
    Bipolar Disord; 2015 Feb; 17(1):63-75. PubMed ID: 25056368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase III trial.
    Sachs GS; Greenberg WM; Starace A; Lu K; Ruth A; Laszlovszky I; Németh G; Durgam S
    J Affect Disord; 2015 Mar; 174():296-302. PubMed ID: 25532076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cariprazine to Treat Schizophrenia and Bipolar Disorder in Adults.
    Edinoff A; Ruoff MT; Ghaffar YT; Rezayev A; Jani D; Kaye AM; Cornett EM; Kaye AD; Viswanath O; Urits I
    Psychopharmacol Bull; 2020 Sep; 50(4):83-117. PubMed ID: 33012874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment).
    Nakamura T; Kubota T; Iwakaji A; Imada M; Kapás M; Morio Y
    Drug Des Devel Ther; 2016; 10():327-38. PubMed ID: 26834462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, Safety, and Tolerability of Cariprazine in Pediatric Patients with Bipolar I Disorder or Schizophrenia.
    Riccobene T; Riesenberg R; Yeung PP; Earley WR; Hankinson AL
    J Child Adolesc Psychopharmacol; 2022 Oct; 32(8):434-443. PubMed ID: 36282772
    [No Abstract]   [Full Text] [Related]  

  • 7. Cariprazine in the treatment of schizophrenia: a proof-of-concept trial.
    Durgam S; Litman RE; Papadakis K; Li D; Németh G; Laszlovszky I
    Int Clin Psychopharmacol; 2016 Mar; 31(2):61-8. PubMed ID: 26655732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: a phase II, randomized clinical trial.
    Durgam S; Starace A; Li D; Migliore R; Ruth A; Németh G; Laszlovszky I
    Schizophr Res; 2014 Feb; 152(2-3):450-7. PubMed ID: 24412468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cariprazine across the symptoms of mania in bipolar I disorder: Analyses of pooled data from phase II/III trials.
    Vieta E; Durgam S; Lu K; Ruth A; Debelle M; Zukin S
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):1882-91. PubMed ID: 26419293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and tolerability of cariprazine in patients with manic or mixed episodes associated with bipolar I disorder: A 16-week open-label study.
    Ketter TA; Sachs GS; Durgam S; Lu K; Starace A; Laszlovszky I; Németh G
    J Affect Disord; 2018 Jan; 225():350-356. PubMed ID: 28843918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression.
    Durgam S; Earley W; Lipschitz A; Guo H; Laszlovszky I; Németh G; Vieta E; Calabrese JR; Yatham LN
    Am J Psychiatry; 2016 Mar; 173(3):271-81. PubMed ID: 26541814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population Pharmacokinetics of Cariprazine and its Major Metabolites.
    Periclou A; Phillips L; Ghahramani P; Kapás M; Carrothers T; Khariton T
    Eur J Drug Metab Pharmacokinet; 2021 Jan; 46(1):53-69. PubMed ID: 33141308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of cariprazine across symptom domains in patients with acute exacerbation of schizophrenia: Pooled analyses from 3 phase II/III studies.
    Marder S; Fleischhacker WW; Earley W; Lu K; Zhong Y; Németh G; Laszlovszky I; Szalai E; Durgam S
    Eur Neuropsychopharmacol; 2019 Jan; 29(1):127-136. PubMed ID: 30470662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Cariprazine in Acute Management of Psychiatric Disorders: a Meta-Analysis of Randomized Controlled Trials.
    Cooper H; Mishriky R; Reyad AA
    Psychiatr Danub; 2020; 32(1):36-45. PubMed ID: 32303028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study.
    Calabrese JR; Keck PE; Starace A; Lu K; Ruth A; Laszlovszky I; Németh G; Durgam S
    J Clin Psychiatry; 2015 Mar; 76(3):284-92. PubMed ID: 25562205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cariprazine for the treatment of bipolar mania with mixed features: A post hoc pooled analysis of 3 trials.
    McIntyre RS; Masand PS; Earley W; Patel M
    J Affect Disord; 2019 Oct; 257():600-606. PubMed ID: 31344528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global improvement with cariprazine in the treatment of bipolar I disorder and schizophrenia: A pooled post hoc analysis.
    Durgam S; Earley W; Lu K; Németh G; Laszlovszky I; Volk S; Litman RE
    Int J Clin Pract; 2017 Dec; 71(12):. PubMed ID: 29119668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review with Meta-Analysis of Randomized Controlled Trials.
    Lao KS; He Y; Wong IC; Besag FM; Chan EW
    CNS Drugs; 2016 Nov; 30(11):1043-1054. PubMed ID: 27550371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of cariprazine in psychiatric disorders: A systematic review.
    Chhatlani A; Farheen SA; Setty MJ; Tampi RR
    Ann Clin Psychiatry; 2018 Nov; 30(4):326-334. PubMed ID: 30372510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An excitement subscale of the Positive and Negative Syndrome Scale.
    Lindenmayer JP; Brown E; Baker RW; Schuh LM; Shao L; Tohen M; Ahmed S; Stauffer VL
    Schizophr Res; 2004 Jun; 68(2-3):331-7. PubMed ID: 15099614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.